Email UpdatesThis document summarizes a discussion from a workshop where experts examined the evidence for candidate endpoints and study design strategies for clinical trials of stimulant use disorder treatments.
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
File Size
674 KB KB
Year
Format
Report/Paper/Issue Brief
Terms of Use
Copyrighted, freely available
Topic
Stimulant Use Disorders
Polysubstance Use
Co-Occurring Behavioral Health Disorders
Prescribing Opioids
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Resource Type
PDF
Use
Prevention of Substance Use Disorder
Special Collection
MAT Tools and Resources